The Faculty of Medicine at The Chinese University of Hong Kong has been ranked second globally in Gastroenterology and Hepatology. This achievement reflects the institution's ongoing success in clinical innovation and medical research.

Researchers argue that steatotic liver disease should be managed as an evolving trajectory rather than a static diagnosis to account for fluctuating metabolic and alcohol-related risks.